WO2023152671 - PHARMACEUTICAL COMPOSITIONS COMPRISING A 225-ACTINIUM-LABELLED COMPLEX AND A BISMUTH SEQUESTERING AGENT

National phase entry:
Publication Number WO/2023/152671
Publication Date 17.08.2023
International Application No. PCT/IB2023/051159
International Filing Date 09.02.2023
Title [English] PHARMACEUTICAL COMPOSITIONS COMPRISING A 225-ACTINIUM-LABELLED COMPLEX AND A BISMUTH SEQUESTERING AGENT [French] COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN COMPLEXE MARQUÉ PAR 225-ACTINIUM ET UN AGENT SÉQUESTRANT LE BISMUTH
Applicants ** NOVARTIS AG Lichtstrasse 35 4056 Basel, CH
Inventors ** CASTALDI, Elena c/o Advanced Accelerator Applications (Italy) - S.R.L., Via dell'Industria Prima Traversa 86077 Pozilli, IT ZAHI, Ilyes 20 Rue Diesel 01630 Saint-Genis-Poulilly, FR FORMENTO CAVAIER, Roberto c/o Advanced Accelerator Applications (Italy) - S.R.L., Via dell'Industria Prima Traversa 086077 Pozzilli, IT MAINERO, Valentina c/o Advanced Accelerator Applications (Italy) - S.R.L, Via dell'industria Prima Traversa 86077 Pozzilli, IT MARIANI, Maurizio F c/o Advanced Accelerator Applications (Italy) - S.R.L. Via dell'industria Prima Traversa 86077 Pozzilli (Isernia), IT
Priority Data 63/308,211  09.02.2022  US
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 1338
EPO Filing, Examination 6852
Japan Filing 580
South Korea Filing 576
USA Filing, Examination 2835
MasterCard Visa
Total: 12181
The term for entry into the National Phase has expired. This quotation is for informational purposes only.

Abstract [English] . The disclosure also concerns a method for preparing said pharmaceutical composition. [French] . L'invention concerne également un procédé de préparation de ladite composition pharmaceutique.